Differentiated thyroid cancer in navarra (Spain): historic cohort results (1987-2003)
- PMID: 22084734
- PMCID: PMC3195983
- DOI: 10.5402/2011/560503
Differentiated thyroid cancer in navarra (Spain): historic cohort results (1987-2003)
Abstract
Introduction. Navarra has the highest incidence of differentiated thyroid cancer in Spain. The aim of this study was to review its management carried out by the Navarra's multidisciplinary Thyroid Disease Unit, from 1987 to 2003. Material and Methods. 325 patients were studied to find the incidence, prevalence, and prognostic factors. Statistical analysis comprised univariate and multivariate Cox proportional hazards regression models for survival and tumor recurrence. Results. The average annual incidence was 3.6 per 100,000 inhabitants, with a final prevalence of 82.4 per 100,000. Regarding survival and recurrence, statistical significance was observed for stage IV, follicular carcinoma, capsular and prethyroid muscles invasion, and T4 group. Only survival was related to tumour size larger than 40 mm. Only recurrence was related to lymph node metastases and radioiodine dose higher than 100 mCi. Conclusions. Attendance of patients in a functional unit setting has allowed us to classify them into three risk groups.
Figures
Similar articles
-
Prognostic impact of incomplete surgical clearance of radioiodine sensitive local lymph node metastases diagnosed by post-operative (124)I-NaI-PET/CT in patients with papillary thyroid cancer.Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1988-94. doi: 10.1007/s00259-016-3400-y. Epub 2016 Apr 27. Eur J Nucl Med Mol Imaging. 2016. PMID: 27118127
-
Increased incidence of thyroid cancer in Navarra (Spain). Evolution and clinical characteristics, 1986-2010.Endocrinol Diabetes Nutr. 2017 Jun-Jul;64(6):303-309. doi: 10.1016/j.endinu.2017.02.013. Epub 2017 May 11. Endocrinol Diabetes Nutr. 2017. PMID: 28604340 English, Spanish.
-
Prognostic factors in follicular carcinoma of the thyroid--a multivariate survival analysis.Eur J Surg Oncol. 1999 Dec;25(6):599-605. doi: 10.1053/ejso.1999.0714. Eur J Surg Oncol. 1999. PMID: 10556007
-
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.Endocr Relat Cancer. 2005 Dec;12(4):773-803. doi: 10.1677/erc.1.00880. Endocr Relat Cancer. 2005. PMID: 16322322 Review.
-
[Long-term course in differentiated thyroid gland carcinoma].Schweiz Med Wochenschr. 1992 Nov 28;122(48):1843-57. Schweiz Med Wochenschr. 1992. PMID: 1462145 Review. German.
References
-
- Carvajal VL, Santamaría MP. Epidemiología del cáncer diferenciado de tiroides. Endocrinologia y Nutricion. 2005;52(1):2–10.
-
- Ponce Marco JL. Cáncer de tiroides. In: Garcia JLL, editor. Cirugía AEC: Manual de la Asociación Española de Cirujanos. 1st edition. chapter 67. Madrid, Spain: Médica Panamericana; 2005. pp. 630–645.
-
- Sitges Serra A, Sancho Inserser J. Carcinoma diferenciado de tiroides, carcinoma medular de tiroides, carcinoma anaplásico de tiroides y linfoma tiroideo. In: Serra AS, Inserser JS, editors. Guías Clínicas de la Asociación Española de Cirujanos. 1st edition. chapter 2. Madrid, Spain: Arán Ediciones; 1999. pp. 27–50. (Cirugía Endocrina).
-
- Riesco-Eizaguirre G, Santisteban P. Molecular biology of thyroid cancer initiation. Clinical and Translational Oncology. 2007;9(11):686–693. - PubMed
-
- Schlumberger M, Berg G, Cohen O, et al. Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective. European Journal of Endocrinology. 2004;150(2):105–112. - PubMed
LinkOut - more resources
Full Text Sources